Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells
Michael G. Kharas, … , Kevan M. Shokat, David A. Fruman
Michael G. Kharas, … , Kevan M. Shokat, David A. Fruman
Published June 1, 2017
Citation Information: J Clin Invest. 2017;127(6):2438-2438. https://doi.org/10.1172/JCI95182.
View: Text | PDF | Amended Article
Corrigendum

Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells

Abstract

Authors

Michael G. Kharas, Matthew R. Janes, Vanessa M. Scarfone, Michael B. Lilly, Zachary A. Knight, Kevan M. Shokat, David A. Fruman

×

Full Text PDF | Download (293.00 KB)